Inhibition of insulin‐like growth factor 1 receptor enhances the efficacy of sorafenib in inhibiting hepatocellular carcinoma cell growth and survival-Reference-Cited by-同舟云学术

Inhibition of insulin‐like growth factor 1 receptor enhances the efficacy of sorafenib in inhibiting hepatocellular carcinoma cell growth and survival

Published:2018-04-17 Issue:6 Volume:2 Page:732-746
ISSN:2471-254X
Container-title:Hepatology Communications
language:en
Short-container-title:Hepatology Communications

Author:

Wang Fang¹,Bank Thomas¹,Malnassy Gregory¹,Arteaga Maribel¹,Shang Na¹,Dalheim Annika¹,Ding Xianzhong²,Cotler Scott J.³,Denning Mitchell F.²,Nishimura Michael I.¹,Breslin Peter¹⁴,Qiu Wei¹^ORCID

Affiliation:

1. Department of Surgery and Oncology Institute, Stritch School of MedicineLoyola University ChicagoMaywood IL

2. Pathology Department, Stritch School of MedicineLoyola University ChicagoMaywood IL

3. Department of Medicine, Stritch School of MedicineLoyola University ChicagoMaywood IL

4. Department of Molecular/Cellular Physiology, Stritch School of MedicineLoyola University ChicagoMaywood IL

Funder

American Association for the Study of Liver Diseases

National Institutes of Health

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep4.1181

Reference38 articles.

1. Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region

2. Concurrent versus Sequential Sorafenib Therapy in Combination with Radiation for Hepatocellular Carcinoma

3. Sa1701 Cytotoxic T Lymphocyte Antigen-4 (Ctla-4) Signaling Effectively Retains Regulatory T Cells (Treg) to Alleviate Liver Injury of Patients With Acute-on-Chronic Hepatitis B (Achb)

4. Sorafenib

5. Activation of Phosphatidylinositol 3-Kinase/Akt Signaling Pathway Mediates Acquired Resistance to Sorafenib in Hepatocellular Carcinoma Cells

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Implications of Ceritinib in Cholangiocarcinoma beyond ALK Expression and Mutation;Pharmaceuticals;2024-02-02

2. Cyclodextrin Based Host-Guest Inclusion Complex, an Approach to Enhancing the Physicochemical and Biopharmaceutical Application of Poorly Water-soluble Drugs;Chemical Research in Chinese Universities;2023-10-14

3. Dysregulated Signalling Pathways Driving Anticancer Drug Resistance;International Journal of Molecular Sciences;2023-07-30

4. Potential Treatment Strategies for Hepatocellular Carcinoma Cell Sensitization to Sorafenib;Journal of Hepatocellular Carcinoma;2023-02

5. Niclosamide Revitalizes Sorafenib through Insulin-like Growth Factor 1 Receptor (IGF-1R)/Stemness and Metabolic Changes in Hepatocellular Carcinoma;Cancers;2023-02-01